Pfizer Global Medical Grants (GMG) – Now LIVE!

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.

 I would like to share a new RFP that may be of interest to you. This RFP is focused on supporting independent research initiatives.

 If you have any questions about this RFP or the grant application process, please contact my colleague, Jessica Romano, at [email protected].


 

Grant 1: 2022/2023 Global Cachexia ASPIRE

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.

For all Investigator Sponsored Research (ISRs) and general research grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. Pfizer must not be involved in any aspect of study protocol or project development, nor the conduct or monitoring of the research program. An ISR grant request cannot be submitted for a study that has already commenced and was not originally supported by Pfizer.

 

Date RFP Issued: September 20, 2022

Geographic Scope: Global

Clinical Area: Cachexia

Link to full RFP: 2022/2023 Global Cachexia ASPIRE

Application Due Date: January 5, 2023

Specific Area of Interest: The intent of this RFP is to support research projects in the following categories:

Evidence generation in Understanding Cachexia/Unintentional Weight Loss in Cancer or Heart Failure
Role of GDF-15/GFRAL Pathway in Disease
GDF-15/GFRAL Biology
Natural History (longitudinal) studies specifically related to cachexia/weight loss and/or heart failure


 

Grant 2: Engaging the Patient Community in Research and Publications

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to help improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s areas of interest. Consistent with Pfizer’s commitment to putting patients first, we are proud to collaborate with the Stanford Medicine AIM lab to release this RFP to support patient-powered research.

For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.

 

Date RFP Issued: October 20, 2022

Geographic Scope: United States, Canada and Europe

Clinical Area: Infectious disease, drug resistant infections, Oncology and Internal Medicine

Link to full RFP: Engaging the Patient Community in Research and Publications

Application Due Date: December 8, 2022

Specific Area of Interest: Through this RFP, we intend to provide grants to strengthen the capabilities of the patient community by providing mentorship and training on how to conduct patient-partnered research with the goal to facilitate increased opportunities for collaboration between patients and academic-research communities.

Latest News

By Education & Training Sub-Committee on 21st April 2026

NEW e-learning modules for Gastric and Oesophageal Cancers are now LIVE

The Education and Training subcommittee are pleased to announce that our new e-learning modules for Gastric and Oesophageal Cancers are now live on the BOPA website. These modules can be…

Read article
By Suriya Marshall on 21st April 2026

Join the CCLG Global Child Cancer group webinar Tackling Drug Quality in Paediatric Oncology in Low- and Middle- Income Countries (LMIC)

Calling all Paediatric Oncologists, Nurses and Pharmacists to collaborate and make a global impact Date: Thursday 14th May 2026 Time: 14:00-16:00 BST Place: Online Teams meeting Serious concerns have been…

Read article
By Farah Al-sheikhli on 16th April 2026

LCC 2026 Funding Opportunity: Pharmacist Reviewers for ‘Let’s Communicate Cancer’ Programme

Let’s Communicate Cancer review 2026 The BOPA Education and Training Subcommittee have a great opportunity for pharmacists to become involved in the review of the ‘Let’s communicate cancer’ training modules.…

Read article
By Farah Al-sheikhli on 16th April 2026

NIHR INSIGHT Opening the Doors: Reimagining Inclusion in Health Research

📅 Friday 5 June 2026  🕐 12:00–16:00  📍 1 Frith Street, London W1D 3HZ ✅ Register here About this event NIHR INSIGHT South London welcomes you to join us for an afternoon dedicated…

Read article